Mantle Cell Lymphoma (MCL) Enrolling by Invitation Phase 2 Trials for Ibrutinib (DB09053)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs